FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2170116522> ?p ?o ?g. }

• W2170116522 endingPage "5762" @default.
• W2170116522 startingPage "5750" @default.
• W2170116522 abstract "Our focus was on patients with pediatric acute lymphoblastic leukemia (ALL) who experienced relapse or died without becoming transplantation candidates. The purpose was to outline measures needed to improve the outcome.We analyzed our population-based 20-year data on 3,385 Nordic children with ALL treated on Nordic Society for Pediatric Hematology and Oncology ALL protocols, and described the flow of these patients through relapses, remissions, and deaths as a result of toxicity, demonstrating where major patient losses occurred.In total, 854 patients (25%) had a first and 274 patients (8%) had a second ALL relapse. P for survival after the first relapse was .35 +/- .02. The induction mortality (2.2%, primary; 10.3%, first relapse; 26.3%, second relapse) and remission mortality (1%, first complete remission [1CR]; 19%, second CR [2CR]) were significant; transplantation-related mortality (TRM) only represented 15% (69 of 459) of the deaths as a result of toxicity. Of the 766 patients entering 2CR, 29% underwent transplantation (P for survival, .46 +/- .04), whereas 71% continued receiving chemotherapy (P for survival, .39 +/- .02). Children with stem-cell transplantation indications in 2CR, if they did not undergo transplantation, generally died or had a second relapse. The patient groups that underwent transplantation in 1CR (n = 84), 2CR (n = 220), and > or = 3CR (n = 62) represented different risk profiles. Those with allogeneic stem-cell transplantation (allo-SCT) in > or = 3CR (P for survival, .37 +/- .07) had an ALL and first relapse with favorable features.Major patient losses occurred through mortality as a result of toxicity and resistant disease during the pathways before allo-SCT. After relapse, more patients were lost to mortality as a result of toxicity during conventional chemotherapy compared with TRM. After second relapse, the chance for rescue by allo-SCT in 3CR was minimal. The question of whether transplantation is recommended after ALL relapse should be carefully addressed, and more efficient relapse protocols should be launched." @default.
• W2170116522 created "2016-06-24" @default.
• W2170116522 creator A5001070816 @default.
• W2170116522 creator A5014035265 @default.
• W2170116522 creator A5017647313 @default.
• W2170116522 creator A5043201493 @default.
• W2170116522 creator A5047659150 @default.
• W2170116522 creator A5052432413 @default.
• W2170116522 creator A5061345880 @default.
• W2170116522 creator A5062993668 @default.
• W2170116522 creator A5065016973 @default.
• W2170116522 creator A5066050875 @default.
• W2170116522 creator A5082007290 @default.
• W2170116522 creator A5084039457 @default.
• W2170116522 creator A5091081498 @default.
• W2170116522 date "2006-12-20" @default.
• W2170116522 modified "2023-10-17" @default.
• W2170116522 title "Pathways Through Relapses and Deaths of Children With Acute Lymphoblastic Leukemia: Role of Allogeneic Stem-Cell Transplantation in Nordic Data" @default.
• W2170116522 cites W1611176785 @default.
• W2170116522 cites W1968023309 @default.
• W2170116522 cites W1969261073 @default.
• W2170116522 cites W1980662330 @default.
• W2170116522 cites W1994700885 @default.
• W2170116522 cites W2007208181 @default.
• W2170116522 cites W2024330902 @default.
• W2170116522 cites W2025056580 @default.
• W2170116522 cites W2038252730 @default.
• W2170116522 cites W2063207305 @default.
• W2170116522 cites W2090340916 @default.
• W2170116522 cites W2094860555 @default.
• W2170116522 cites W2118457944 @default.
• W2170116522 cites W2126838987 @default.
• W2170116522 cites W2127153931 @default.
• W2170116522 cites W2144114258 @default.
• W2170116522 cites W2145641630 @default.
• W2170116522 cites W2154267224 @default.
• W2170116522 cites W2154941073 @default.
• W2170116522 cites W2156012548 @default.
• W2170116522 cites W2167135900 @default.
• W2170116522 cites W2252635646 @default.
• W2170116522 cites W2259248272 @default.
• W2170116522 cites W2407208193 @default.
• W2170116522 cites W4238048948 @default.
• W2170116522 cites W4293241248 @default.
• W2170116522 cites W43502357 @default.
• W2170116522 doi "https://doi.org/10.1200/jco.2006.07.1225" @default.
• W2170116522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17179109" @default.
• W2170116522 hasPublicationYear "2006" @default.
• W2170116522 type Work @default.
• W2170116522 sameAs 2170116522 @default.
• W2170116522 citedByCount "56" @default.
• W2170116522 countsByYear W21701165222012 @default.
• W2170116522 countsByYear W21701165222013 @default.
• W2170116522 countsByYear W21701165222014 @default.
• W2170116522 countsByYear W21701165222015 @default.
• W2170116522 countsByYear W21701165222016 @default.
• W2170116522 countsByYear W21701165222017 @default.
• W2170116522 countsByYear W21701165222018 @default.
• W2170116522 countsByYear W21701165222019 @default.
• W2170116522 countsByYear W21701165222020 @default.
• W2170116522 countsByYear W21701165222021 @default.
• W2170116522 countsByYear W21701165222022 @default.
• W2170116522 countsByYear W21701165222023 @default.
• W2170116522 crossrefType "journal-article" @default.
• W2170116522 hasAuthorship W2170116522A5001070816 @default.
• W2170116522 hasAuthorship W2170116522A5014035265 @default.
• W2170116522 hasAuthorship W2170116522A5017647313 @default.
• W2170116522 hasAuthorship W2170116522A5043201493 @default.
• W2170116522 hasAuthorship W2170116522A5047659150 @default.
• W2170116522 hasAuthorship W2170116522A5052432413 @default.
• W2170116522 hasAuthorship W2170116522A5061345880 @default.
• W2170116522 hasAuthorship W2170116522A5062993668 @default.
• W2170116522 hasAuthorship W2170116522A5065016973 @default.
• W2170116522 hasAuthorship W2170116522A5066050875 @default.
• W2170116522 hasAuthorship W2170116522A5082007290 @default.
• W2170116522 hasAuthorship W2170116522A5084039457 @default.
• W2170116522 hasAuthorship W2170116522A5091081498 @default.
• W2170116522 hasConcept C126322002 @default.
• W2170116522 hasConcept C141071460 @default.
• W2170116522 hasConcept C187212893 @default.
• W2170116522 hasConcept C194409129 @default.
• W2170116522 hasConcept C2776863199 @default.
• W2170116522 hasConcept C2778461978 @default.
• W2170116522 hasConcept C28328180 @default.
• W2170116522 hasConcept C2908647359 @default.
• W2170116522 hasConcept C2911091166 @default.
• W2170116522 hasConcept C29730261 @default.
• W2170116522 hasConcept C54355233 @default.
• W2170116522 hasConcept C71924100 @default.
• W2170116522 hasConcept C86803240 @default.
• W2170116522 hasConcept C99454951 @default.
• W2170116522 hasConceptScore W2170116522C126322002 @default.
• W2170116522 hasConceptScore W2170116522C141071460 @default.
• W2170116522 hasConceptScore W2170116522C187212893 @default.
• W2170116522 hasConceptScore W2170116522C194409129 @default.
• W2170116522 hasConceptScore W2170116522C2776863199 @default.
• W2170116522 hasConceptScore W2170116522C2778461978 @default.
• W2170116522 hasConceptScore W2170116522C28328180 @default.

• next